Jazz Pharmaceuticals plc (J7Z) — Cash Flow Reinvestment Rate

Latest as of March 2026: 0.59x

Jazz Pharmaceuticals plc (J7Z) has a Cash Flow Reinvestment Rate of 0.59x as of March 2026, reinvesting €239.70 Million (capex €19.70 Million plus investments €220.00 Million) from operating cash flow of €408.20 Million. Check J7Z cash flow quality score to evaluate the quality of earnings relative to operating cash generation.

Reinvestment Rate

0.59x
(Capex + Investments) / Operating CF

Total Reinvested

€239.70 Million
Capex + Investments

Operating Cash Flow

€408.20 Million
EUR

Capital Expenditures

€19.70 Million
EUR

Jazz Pharmaceuticals plc Cash Flow Reinvestment Rate (2013–2025)

Historical reinvestment intensity for Jazz Pharmaceuticals plc across 13 annual periods. Explore Jazz Pharmaceuticals plc long-term investment allocation to see how much of total assets are deployed in long-term investments.

Annual Cash Flow Reinvestment Rate for Jazz Pharmaceuticals plc (2013–2025)

Year-by-year capital reinvestment analysis for Jazz Pharmaceuticals plc. For live market cap and broader valuation context, see Jazz Pharmaceuticals plc (J7Z) total market value.

Year Reinvestment Rate Total Reinvested (EUR) Operating CF Capex YoY Change
2025 0.50x €680.03 Million €1.36 Billion €209.75 Million ▲ +37.8%
2024 0.36x €508.19 Million €1.40 Billion €48.07 Million ▲ +143.8%
2023 0.15x €163.06 Million €1.09 Billion €42.96 Million ▲ +531.4%
2022 0.02x €30.08 Million €1.27 Billion €29.05 Million ▼ -98.3%
2021 1.41x €1.10 Billion €778.51 Million €27.64 Million ▲ +92.5%
2020 0.73x €657.68 Million €899.65 Million €15.00 Million ▲ +425.4%
2019 0.14x €108.03 Million €776.40 Million €40.13 Million ▼ -66.4%
2018 0.41x €331.29 Million €798.90 Million €20.37 Million ▲ +56.2%
2017 0.27x €183.95 Million €693.09 Million €28.95 Million ▼ -91.9%
2016 3.26x €1.93 Billion €592.39 Million €181.58 Million ▲ +1612.7%
2015 0.19x €101.23 Million €531.94 Million €35.96 Million ▼ -23.7%
2014 0.25x €101.62 Million €407.61 Million €36.35 Million ▼ -4.4%
2013 0.26x €75.25 Million €288.43 Million €9.98 Million —
Cash Flow Reinvestment Rate = (ABS(Capex) + ABS(Investments)) / Operating Cash Flow